Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Futures Intelligence

Index Tracker: Asset flows and various indexes.

Tuesday, May 19, 2009

Index Tracker

Managed futures as a whole continued to lose in April, as the Newedge, Barclay and Credit Suisse /Tremont indexes indicate. To see what's happening at a more granular level, take a look at Australian Fund Monitors' indexes, which cover more than 200 absolute return and hedge funds managed in Australia.

This database breaks out commodity and currency CTAs separately from managed futures. Australian commodity managers were about flat for the month while FX performed strongly.

When it came to new allocations, investors favored managed futures and global macro. According to Barclay Hedge, $31.4 billion left hedge funds in March, the fifth largest outflow on record, bringing first quarter redemptions to $137 billion or 12.6% of industry assets. But CTAs posted their first inflow in seven months, getting $695 million (0.4% of assets). Global macro was the only other sector that had a positive asset inflow.

Other databases point in the same direction, though the exact numbers differ. A report from Credit Suisse /Tremont says that overall assets under management by hedge funds declined to $1.3 trillion as of March 31st. While investors, in particular institutions, are expected to return to hedge funds in time, “Over the short term, we anticipate increased attention will be focused on specific sectors such as global macro, convertible arbitrage and managed futures.”

Here is what Credit Suisse /Tremont says about investors' interest:“Despite finishing the first quarter down 2.9%, funds in the managed futures space, which represented the best performing hedge fund sector last year, continue to build on the interest they generated in 2008. The liquid, trend-following nature of this strategy typically allows managers to react quickly to changing market conditions, which in turn has historically enabled managers to capitalize during periods of increased market volatility.”

April and Year-to-Date Returns, Various Indexes

 AprYTD
Australian Fund Monitors: 
Commodities/CTA0.16%-0.20%
Currency/FX1.68%1.92%
Global Macro0.17%-0.63%
Managed Futures-0.83%1.35%
All Hedge Funds3.09% 4.01%
Newedge CTA Index-1.96-4.0%
Barclay CTA Index - 0.51%- 2.34%
Credit Suisse /Tremont 
Managed Futures-3.24%-6.03%
Hedge Fund Index 1.68%2.55%



 
This article was published in Opalesque Futures Intelligence.
Opalesque Futures Intelligence
Opalesque Futures Intelligence
Opalesque Futures Intelligence
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its